# Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/liberty-asthma-quest-phase-3-randomized-double-blind-placebo-controlled-parallel/

## Facts

| Field | Value |
| --- | --- |
| Author Names | William W. Busse,Jorge Máspero,Klaus F. Rabe,Alberto Papi,Sally E. Wenzel,Linda B. Ford,Ian Pavord,Bingzhi Zhang,Heribert Staudinger,Gianluca Pirozzi,Nikhil Amin,Bolanle Akinlade,Laurent Eckert,Jingdong Chao,Neil M.H. Graham,Ariel Teper |
| Citations | 185 |
| DOI | 10.1007/s12325-018-0702-4 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s12325-018-0702-4.pdf |
| OpenAlex ID | https://openalex.org/W2801759342 |
| PMID | 29725983 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Jingdong Chao](https://scholariq.org/researchers/jingdong-chao/)

## Paper journal

- [Advances in Therapy](https://scholariq.org/journals/advances-in-therapy/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [IL-33, ST2, and ILC Pathways](https://scholariq.org/topics/il-33-st2-and-ilc-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.